{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T20:33:03Z","timestamp":1781382783582,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jocn.2024.110816","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T17:43:38Z","timestamp":1725212618000},"page":"110816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Herpes zoster in patients with glioma treated with temozolomide"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-2580","authenticated-orcid":false,"given":"Alison","family":"Hiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam H.","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Gately","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malaka","family":"Ameratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.110816_b0005","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S1470-2045(16)30313-8","article-title":"Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033\u201326033): a randomised, open-label, phase 3 intergroup study","volume":"17","author":"Baumert","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jocn.2024.110816_b0010","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2013.49.6968","article-title":"Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial","volume":"31","author":"Gilbert","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2024.110816_b0015","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/imj.12599","article-title":"Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014","volume":"44","author":"Cooley","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jocn.2024.110816_b0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.critrevonc.2012.08.002","article-title":"Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas","volume":"85","author":"De Vos","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jocn.2024.110816_b0025","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jocn.2024.110816_b0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2169\/internalmedicine.33.733","article-title":"Circadian Variations and Prednisolone-Induced Alterations of Circulating Lymphocyte Subsets in Man","volume":"33","author":"Fukuda","year":"1994","journal-title":"Intern Med"},{"key":"10.1016\/j.jocn.2024.110816_b0035","first-page":"479","article-title":"Prednisone-induced alterations of circulating human lymphocyte subsets","volume":"101","author":"Slade","year":"1983","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jocn.2024.110816_b0040","doi-asserted-by":"crossref","first-page":"e14533","DOI":"10.1200\/JCO.2020.38.15_suppl.e14533","article-title":"Effect of cumulative dexamethasone dose during concomitant chemoradiation on lymphopenia in patients with newly diagnosed glioblastoma","volume":"38","author":"Ahn","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2024.110816_b0045","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jocn.2024.110816_b0050","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.110816_b0055","unstructured":"National Cancer Institute (2017) Common Terminology Criteria for Adverse Events (CTCAE) v5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm. Accessed 17 Mar 2024."},{"key":"10.1016\/j.jocn.2024.110816_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2024.110816_b0065","doi-asserted-by":"crossref","first-page":"e020528","DOI":"10.1136\/bmjopen-2017-020528","article-title":"Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000\u20132012","volume":"8","author":"Yanni","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jocn.2024.110816_b0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12879-015-0810-6","article-title":"The epidemiology of herpes zoster and its complications in Medicare cancer patients","volume":"15","author":"Yenikomshian","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jocn.2024.110816_b0075","doi-asserted-by":"crossref","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, et al (2014) Quantification of risk factors for herpes zoster: population based case-control study. BMJ g2911. 10.1136\/bmj.g2911.","DOI":"10.1136\/bmj.g2911"},{"key":"10.1016\/j.jocn.2024.110816_b0080","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1186\/s12879-020-05648-6","article-title":"Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009\u20132014","volume":"20","author":"Mu\u00f1oz-Quiles","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jocn.2024.110816_b0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10147-020-01814-7","article-title":"Hepatitis B virus reactivation during temozolomide administration for malignant glioma","volume":"26","author":"Shoji","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jocn.2024.110816_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30220","article-title":"Viral infections in pediatric brain tumor patients treated with targeted therapies","volume":"70","author":"Mayr","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jocn.2024.110816_b0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/B:NEON.0000040837.68411.97","article-title":"Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas","volume":"70","author":"Spence","year":"2004","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110816_b0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/cns.14.24","article-title":"Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis","volume":"3","author":"Neuwelt","year":"2014","journal-title":"CNS Oncol"},{"key":"10.1016\/j.jocn.2024.110816_b0105","unstructured":"US Food and Drug Administration (2023) SHINGRIX. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/shingrix#authorisation-details-section. Accessed 30 Mar 2024."},{"key":"10.1016\/j.jocn.2024.110816_b0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2024.110816_b0115","unstructured":"Department of Health and Aged Care (2023) Shingles (herpes zoster) vaccine. In: Department of Health and Aged Care. https:\/\/www.health.gov.au\/topics\/immunisation\/vaccines\/shingles-herpes-zoster-immunisation-service. Accessed 17 Mar 2024."},{"key":"10.1016\/j.jocn.2024.110816_b0120","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2024.110816_b0125","unstructured":"eviQ Cancer Treatments Online CIN (2023) Prophylaxis - Pneumocystis jirovecii (carinii) pneumonia in cancer patients. https:\/\/www.eviq.org.au\/p\/220. Accessed 25 Mar 2024."},{"key":"10.1016\/j.jocn.2024.110816_b0130","unstructured":"National Comprehensive Cancer Network (2023) Prevention and Treatment of Cancer-Related Infections. https:\/\/www.nccn.org\/guidelines\/nccn-guidelines\/guidelines-detail?category=3&id=1457. Accessed 25 Mar 2024."},{"key":"10.1016\/j.jocn.2024.110816_b0135","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/neuonc\/noac072","article-title":"Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy","volume":"24","author":"Climans","year":"2022","journal-title":"Neuro Oncol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824003552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824003552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T12:32:10Z","timestamp":1730377930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824003552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":27,"alternative-id":["S0967586824003552"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110816","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes zoster in patients with glioma treated with temozolomide","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110816"}}